FTXH vs. HELX ETF Comparison
Comparison of First Trust Nasdaq Pharmaceuticals ETF (FTXH) to Franklin Genomic Advancements ETF (HELX)
FTXH
First Trust Nasdaq Pharmaceuticals ETF
FTXH Description
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Grade (RS Rating)
Last Trade
$28.09
Average Daily Volume
3,198
50
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$29.86
Average Daily Volume
2,835
53
Performance
Period | FTXH | HELX |
---|---|---|
30 Days | -0.59% | -4.15% |
60 Days | -3.12% | -8.40% |
90 Days | -3.96% | -10.93% |
12 Months | 16.01% | 7.62% |
16 Overlapping Holdings
Symbol | Grade | Weight in FTXH | Weight in HELX | Overlap | |
---|---|---|---|---|---|
ALNY | D | 0.65% | 1.93% | 0.65% | |
BMRN | D | 0.43% | 0.2% | 0.2% | |
BMY | B | 8.89% | 0.37% | 0.37% | |
CRL | C | 2.47% | 2.04% | 2.04% | |
EXAS | D | 0.44% | 1.32% | 0.44% | |
INSM | C | 0.49% | 2.27% | 0.49% | |
IONS | F | 0.41% | 2.07% | 0.41% | |
KRYS | B | 0.48% | 4.71% | 0.48% | |
LLY | F | 3.11% | 4.49% | 3.11% | |
MEDP | D | 1.79% | 3.87% | 1.79% | |
NBIX | C | 1.39% | 0.96% | 0.96% | |
REGN | F | 2.51% | 4.09% | 2.51% | |
SRPT | D | 0.42% | 1.53% | 0.42% | |
TWST | D | 0.48% | 1.22% | 0.48% | |
UTHR | C | 3.9% | 2.63% | 2.63% | |
VRTX | F | 0.51% | 5.76% | 0.51% |
FTXH Overweight 34 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
JNJ | D | 6.95% | |
PFE | D | 6.81% | |
ABBV | D | 6.56% | |
MRK | F | 6.31% | |
GILD | C | 4.43% | |
CAH | B | 4.09% | |
VTRS | A | 3.97% | |
ZTS | D | 3.61% | |
JAZZ | B | 3.45% | |
AMGN | D | 3.37% | |
BIIB | F | 3.06% | |
OGN | D | 2.43% | |
ELAN | D | 1.83% | |
HALO | F | 1.19% | |
EXEL | B | 1.12% | |
ALKS | B | 1.06% | |
PBH | A | 0.98% | |
PRGO | B | 0.97% | |
CORT | B | 0.82% | |
ACLX | C | 0.73% | |
PTGX | C | 0.71% | |
TGTX | B | 0.69% | |
ITCI | C | 0.63% | |
ADMA | B | 0.62% | |
INCY | C | 0.62% | |
RNA | D | 0.6% | |
AMRX | C | 0.55% | |
VCEL | B | 0.54% | |
ACAD | D | 0.54% | |
BPMC | C | 0.53% | |
KYMR | D | 0.5% | |
ROIV | C | 0.5% | |
VKTX | F | 0.44% | |
MYGN | F | 0.29% |
FTXH Underweight 37 Positions Relative to HELX
Symbol | Grade | Weight | |
---|---|---|---|
NTRA | B | -6.07% | |
DHR | F | -4.09% | |
TMO | F | -4.0% | |
CDNS | B | -2.52% | |
CTVA | C | -2.48% | |
AZN | D | -2.39% | |
BNTX | D | -2.24% | |
A | D | -2.14% | |
QGEN | D | -2.01% | |
RVTY | F | -1.96% | |
BRKR | D | -1.95% | |
RARE | D | -1.49% | |
ICLR | D | -1.26% | |
LGND | B | -1.24% | |
RCKT | F | -1.22% | |
LH | C | -1.18% | |
RGEN | D | -1.06% | |
IQV | D | -1.03% | |
TECH | D | -0.98% | |
AZTA | D | -0.97% | |
BEAM | D | -0.95% | |
BBIO | F | -0.89% | |
VYGR | F | -0.82% | |
VCYT | B | -0.61% | |
MRNA | F | -0.59% | |
RXRX | F | -0.58% | |
BIO | D | -0.55% | |
CDMO | B | -0.54% | |
DVAX | C | -0.5% | |
CRSP | D | -0.49% | |
DOCS | C | -0.46% | |
AVTR | F | -0.45% | |
NTLA | F | -0.42% | |
CRNX | C | -0.25% | |
ARE | D | -0.15% | |
FDMT | F | -0.11% | |
SLP | D | -0.1% |
FTXH: Top Represented Industries & Keywords
HELX: Top Represented Industries & Keywords